Promise Lawrence

Pharmacokinetics, Safety and Efficacy of Intravenous Vedolizumab in Paediatric Patients with Ulcerative Colitis or Crohn’s Disease: Results from the Phase 2 HUBBLE Study

D. Turner, J. Hyams, S. Kabilan, 2022, Journal of Crohn's & colitis.